Abstract:Importance: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in the US. Objective: To conduct a targeted systematic review to update the evidence on the effectiveness of screening for COPD and the treatment of COPD to inform the US Preventive Services Task Force (USPSTF) update of the 2016 recommendation statement on COPD screening. Data sources: MEDLINE, the Cochrane Central Register of Controlled Trials, and CINAHL for relevant studies published between January 1, 2015, to January 22, 2021; surveillance through March 25, 2022. Study selection: English-language studies of screening in individuals who do not recognize or report respiratory symptoms; studies of treatment in persons with mild or moderate, or minimally symptomatic, COPD. Data extraction and synthesis: Two reviewers independently appraised the articles and extracted relevant data from fair- or good-quality studies; no quantitative synthesis was conducted. Main outcomes and measures: COPD-related morbidity or mortality, measures of health-related quality of life, and adverse events. Results: The review included no trials on the effectiveness of screening, 3 trials or analyses (n = 20 058) of pharmacologic treatment published since 2015, 13 trials (n = 3657) on nonpharmacologic interventions, and 2 large observational studies (n = 243 517) addressing the harms of pharmacologic treatment published since 2015. The results from the clinical trials of pharmacologic therapy are consistent with the previous review supporting the USPSTF that bronchodilators with or without inhaled corticosteroids can reduce COPD exacerbations and tiotropium can improve health-related quality of life in adults with moderate COPD. Overall, there was no consistent benefit observed for any type of nonpharmacologic intervention across a range of patient outcomes. None of the included treatment trials that reported adverse effects found significant harms. Two large observational studies in a screen-relevant population demonstrated an association of the initiation of a long-acting muscarinic antagonist or long-acting beta agonist with the risk of a serious cardiovascular event in treatment-naïve patients and an association of inhaled corticosteroids use with the risk of developing diabetes. Conclusions and relevance: The findings of this targeted evidence update are generally consistent with the findings of the previous systematic review supporting the 2016 USPSTF recommendation. Evidence of pharmacologic treatment was still largely limited to persons with moderate airflow obstruction, and there was no consistent benefit observed for a range of nonpharmacologic interventions in mild to moderate COPD or in minimally symptomatic persons with COPD.

Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development

How to Read the New Recommendation Statement: Methods Update from the U.S. Preventive Services Task Force

A Health Equity Framework for the US Preventive Services Task Force

Comprehensive Evidence-based Health Maintenance

Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

US Preventive Services Task Force Recommendations on Obesity in Children and Adolescents: Can Evidence Translate to Impact?

Generating evidence to inform an update of asthma clinical practice guidelines: Perspectives from the National Heart, Lung, and Blood Institute

Editor's Choice - European Society for Vascular Surgery Clinical Practice Guideline Development Scheme: An Overview of Evidence Quality Assessment Methods, Evidence to Decision Frameworks, and Reporting Standards in Guideline Development

Screening for Family and Intimate Partner Violence: Recommendation Statement

"Going into the black box": a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations

A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review

Changing recommendations for lung cancer screening: National Lung Cancer Roundtable member perspectives

Screening for Obesity in Adults: Recommendations and Rationale

Evidence synthesis and guideline development in genomic medicine: current status and future prospects

Umbrella and Systematic Review Methodology to Support the 2018 Physical Activity Guidelines Advisory Committee

Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement

A review of the quantitative effectiveness evidence synthesis methods used in public health intervention guidelines

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

Guidance to Best Tools and Practices for Systematic Reviews

U.S. Selected Practice Recommendations for Contraceptive Use, 2024

The American Society for Microbiology collaboration with the CDC Laboratory Medicine Best Practices initiative for evidence-based laboratory medicine